Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 3
1988 2
1989 5
1990 9
1991 9
1992 11
1993 13
1994 7
1995 12
1996 12
1997 16
1998 13
1999 15
2000 18
2001 27
2002 7
2003 24
2004 14
2005 11
2006 14
2007 8
2008 16
2009 6
2010 8
2011 16
2012 6
2013 3
2014 1
2015 1
2016 2
2017 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

297 results
Results by year
Filters applied: . Clear all
Page 1
Complement is activated by IgG hexamers assembled at the cell surface.
Diebolder CA, Beurskens FJ, de Jong RN, Koning RI, Strumane K, Lindorfer MA, Voorhorst M, Ugurlar D, Rosati S, Heck AJ, van de Winkel JG, Wilson IA, Koster AJ, Taylor RP, Saphire EO, Burton DR, Schuurman J, Gros P, Parren PW. Diebolder CA, et al. Among authors: van de winkel jg. Science. 2014 Mar 14;343(6176):1260-3. doi: 10.1126/science.1248943. Science. 2014. PMID: 24626930 Free PMC article.
Efficient generation of stable bispecific IgG1 by controlled Fab-arm exchange.
Labrijn AF, Meesters JI, de Goeij BE, van den Bremer ET, Neijssen J, van Kampen MD, Strumane K, Verploegen S, Kundu A, Gramer MJ, van Berkel PH, van de Winkel JG, Schuurman J, Parren PW. Labrijn AF, et al. Among authors: van de winkel jg. Proc Natl Acad Sci U S A. 2013 Mar 26;110(13):5145-50. doi: 10.1073/pnas.1220145110. Epub 2013 Mar 11. Proc Natl Acad Sci U S A. 2013. PMID: 23479652 Free PMC article.
Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange.
van der Neut Kolfschoten M, Schuurman J, Losen M, Bleeker WK, Martínez-Martínez P, Vermeulen E, den Bleker TH, Wiegman L, Vink T, Aarden LA, De Baets MH, van de Winkel JG, Aalberse RC, Parren PW. van der Neut Kolfschoten M, et al. Among authors: van de winkel jg. Science. 2007 Sep 14;317(5844):1554-7. doi: 10.1126/science.1144603. Science. 2007. PMID: 17872445
Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors.
de Weers M, Tai YT, van der Veer MS, Bakker JM, Vink T, Jacobs DC, Oomen LA, Peipp M, Valerius T, Slootstra JW, Mutis T, Bleeker WK, Anderson KC, Lokhorst HM, van de Winkel JG, Parren PW. de Weers M, et al. Among authors: van de winkel jg. J Immunol. 2011 Feb 1;186(3):1840-8. doi: 10.4049/jimmunol.1003032. Epub 2010 Dec 27. J Immunol. 2011. PMID: 21187443 Free article. Clinical Trial.
Retraction for Lammerts van Bueren et al. The antibody zalutumumab inhibits epidermal growth factor receptor signaling by limiting intra- and intermolecular flexibility.
Lammerts van Bueren JJ, Bleeker WK, Brännström A, Jansson M, Peipp M, Schneider-Merck T, Valerius T, van de Winkel JG, Parren PW. Lammerts van Bueren JJ, et al. Among authors: van de winkel jg. Proc Natl Acad Sci U S A. 2012 Apr 3;109(14):5548. doi: 10.1073/pnas.1203736109. Epub 2012 Mar 19. Proc Natl Acad Sci U S A. 2012. PMID: 22431606 Free PMC article. No abstract available.
IgA Fc receptors.
Monteiro RC, Van De Winkel JG. Monteiro RC, et al. Among authors: van de winkel jg. Annu Rev Immunol. 2003;21:177-204. doi: 10.1146/annurev.immunol.21.120601.141011. Epub 2001 Dec 19. Annu Rev Immunol. 2003. PMID: 12524384 Review.
Human IgG Fc receptors.
Heijnen IA, van de Winkel JG. Heijnen IA, et al. Among authors: van de winkel jg. Int Rev Immunol. 1997;16(1-2):29-55. doi: 10.3109/08830189709045702. Int Rev Immunol. 1997. PMID: 9651785 Review.
Molecular engineering to improve antibodies' anti-lymphoma activity.
Peipp M, van de Winkel JG, Valerius T. Peipp M, et al. Among authors: van de winkel jg. Best Pract Res Clin Haematol. 2011 Jun;24(2):217-29. doi: 10.1016/j.beha.2011.03.004. Epub 2011 May 7. Best Pract Res Clin Haematol. 2011. PMID: 21658620 Review.
297 results